Mutational profiles in triple-negative breast cancer defined by ultradeep multigene sequencing show high rates of PI3K pathway alterations and clinically relevant entity subgroup specific differences-Reference-Cited by-同舟云学术

Mutational profiles in triple-negative breast cancer defined by ultradeep multigene sequencing show high rates of PI3K pathway alterations and clinically relevant entity subgroup specific differences

Published:2014-09-16 Issue:20 Volume:5 Page:9952-9965
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Kriegsmann Mark¹,Endris Volker¹²,Wolf Thomas¹,Pfarr Nicole¹,Stenzinger Albrecht¹,Loibl Sibylle³,Denkert Carsten⁴⁵,Schneeweiss Andreas⁶⁵,Budczies Jan⁴⁵,Sinn Peter¹,Weichert Wilko¹⁶⁵

Affiliation:

1. Institute of Pathology, University of Heidelberg, Germany

2. German Cancer Research Center, Heidelberg, Germany

3. German Breast Group, Neu-Isenburg, Germany

4. Institute of Pathology, University Hospital Charité Berlin, Germany

5. German Cancer Consortium (DKTK), Germany

6. National Center for Tumor Diseases, Heidelberg, Germany

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GluOC promotes proliferation and metastasis of TNBC through the ROCK1 signaling pathway;Cancer Cell International;2024-07-25

2. BTB protein family and human breast cancer: signaling pathways and clinical progress;Journal of Cancer Research and Clinical Oncology;2023-09-08

3. Advances in immunotherapy for triple-negative breast cancer;Molecular Cancer;2023-09-02

4. Radiation Therapy in Patients with Germline Mutations: a Review of the Current Evidence;Current Breast Cancer Reports;2023-08-22

5. Overcoming the Challenges of Phytochemicals in Triple Negative Breast Cancer Therapy: The Path Forward;Plants;2023-06-16